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Abstract
Objective—The potential influence of dietary factors on inflammation is important for cancer 
prevention. Utilizing data from control participants (312 men, 911 women) in two nested case-
control studies of cancer within the Multiethnic Cohort, we examined the associations of red and 
processed meat intake with serum levels of leptin, adiponectin, C-reactive protein (CRP), tumor 
necrosis factor (TNF)-α, and interleukin (IL)-6 and the mediator effect of body mass index (BMI) 
on the above associations (if present).
Methods—Multivariable linear models were applied to assess the association between red and 
processed meat intake at cohort entry and serum biomarker levels measured 9.1 years later after 
adjusting for covariates and to determine the mediator effect of BMI.
Results—Overall red and processed meat intake was positively associated with serum leptin 
levels in men (β=0.180, P=0.0004) and women (β=0.167, P<0.0001). In women, higher red and 
processed meat consumption was significantly associated with higher CRP (β=0.069, P=0.03) and 
lower adiponectin levels (β=−0.082, P=0.005). In mediation analyses with red and processed meat 
intake and BMI as predictors, the associations of red and processed meat with biomarkers 
decreased substantially (as indicated by % change in effect: leptin in men, 13.4%; leptin in 
women, 13.7%; adiponectin in women, −4.7%; CRP in women, 7.4%) and were no longer 
significant (P>0.05), whereas BMI remained significantly associated with serum leptin (men: 
β=3.209, P<0.0001; women: β=2.891, P<0.0001), adiponectin (women: β= −1.085, P<0.0001) 
and CRP (women: β=1.581, P<0.0001).
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Conclusion—The current data suggest that the amount of excess body weight or the degree of 
adiposity may mediate the relations between dietary red and processed meat intake and serum 
biomarkers associated with obesity and inflammation.
INTRODUCTION
Diet and inflammation play important roles in the development of cancer [1, 2]. Several 
possible associations of macro- and micronutrients with chronic inflammation, a risk factor 
for various cancers, have been described [3] in addition to the role of obesity in chronic low 
grade inflammation marked by altered levels of inflammatory markers and adipokines [4, 5]. 
Markers such as leptin and adiponectin may modify the risk of cancer either directly by 
activating signal transduction pathways involved in carcinogenesis or indirectly by affecting 
insulin sensitivity and inflammatory processes [6]. While leptin participates in pro-
inflammatory responses and serves as an important growth factor for cancer [7, 8], 
adiponectin has a strong anti-inflammatory function [9]. C-reactive protein (CRP), 
interleukin-6 (IL-6) and tumor necrosis factor- α (TNF-α) are markers of systematic 
inflammation and have been linked to increased risk of cancer [1, 10].
On the basis of available evidence, the American Institute for Cancer Research (AICR) and 
the World Cancer Research Fund (WCRF) released lifestyle recommendations for the 
prevention of the most common cancers [11, 12], which include the advice to limit the intake 
of red meat to less than 500 g per week, to avoid processed meat, and to consume at least 
400 g of vegetables per day [11, 12]. Red and processed meat consumption may increase 
oxidative stress and inflammation as suggested by associations of red meat with CRP [13–
17]. However, in most studies the associations were attenuated after adjusting for body mass 
index (BMI), and the mediator effect of BMI was not tested [14–17]. One study reported that 
processed meat consumption was borderline associated with higher IL-6, but not with CRP, 
and with lower TNF-α [18]. Further, no study has yet assessed the direct effect of red meat 
intake alone on circulating leptin levels, although a positive correlation between a Western 
dietary pattern and higher serum leptin concentration was reported without determining the 
relative contributions of the various dietary constituents [19]. Given the increasing evidence 
that adiposity and inflammation are key etiologic factors for cancer development, it is 
important to understand the potential influence of dietary components on adipokines and 
inflammatory markers. Therefore, the current study examined the associations of dietary red 
and processed meat intake with serum levels of CRP, TNF-α, IL-6, leptin, and adiponectin 
among control participants in two nested case-control studies of cancer in the Multiethnic 
Cohort (MEC). In addition, we sought to determine whether the associations between red 
and processed meat intake and biomarker levels, if present were mediated by BMI, and were 
consistent across race/ethnic groups in the MEC.
MATERIALS AND METHODS
Study population and data collection
The current study used data collected from control participants (312 men and 911 women), 
free of cancer, who participated in nested case-control studies of breast cancer and non-
Hodgkin lymphoma conducted within the MEC [20–22], a longitudinal study designed to 
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investigate the association of dietary, lifestyle, and genetic factors with the incidence of 
cancer. The cohort was assembled in Hawaii and Los Angeles in 1993–1996, and details on 
recruitment and baseline information were reported previously [20]. Briefly, subjects from 5 
main race/ethnic groups (whites, Japanese Americans, Latinos, African Americans, and 
Native Hawaiians) were identified primarily through drivers’ license files, supplemented 
with voter registration lists in Hawaii and Medicare files in California, and were recruited by 
mailing a self-administered, 26-page questionnaire on diet, anthropometric measures, 
medical history, family history of cancer, and lifestyle. A total of 215,251 men and women 
aged 45 to 75 years were included at baseline and formed a representative group of the 
general population as verified by a comparison of the cohort distributions across educational 
levels and marital status with corresponding census data for the two geographical areas [20]. 
During 2003–2007, approximately 50% of cohort members completed a full questionnaire 
(Qx3) asking about diet and body weight within 2 years of the collection of blood 
specimens, which were analyzed for serum biomarker levels. The study protocol was 
approved by the Institutional Review Boards of the University of Hawaii and the University 
of Southern California.
A biospecimen subcohort of 67,594 cohort members was established in 2001–2006 by 
asking surviving cohort members to provide blood and urine specimens [23]. When 
comparing the characteristics at cohort entry of individuals who provided specimens with 
those who did not, there were no substantial differences between the two groups in BMI, 
dietary fat and vegetable intake, physical activity, and family history of cancer, suggesting 
that the biospecimen repository participants are broadly representative of the cohort 
members. For nested case-control studies of breast cancer and non-Hodgkin lymphoma, 
incident cancer cases within the MEC were identified by routine linkages to the Hawaii 
Tumor Registry, the Los Angeles County Cancer Surveillance Program, and the State of 
California Cancer Registry, which are participants of the Surveillance, Epidemiology, and 
End Results (SEER) program. Controls were identified from the biospecimen subcohort who 
were alive and free of cancer at the age of the case’s diagnosis and matched on sex, birth 
date (±1 year), race/ethnicity (white, Japanese American, Latino, African American, or 
Native Hawaiian), location (California or Hawaii), date (± 6 months) and time of blood draw 
(±2 hours), fasting hours prior to blood draw (0 to <6, 6 to <8, 8 to <10, and ≥10 hours), and 
hormone replacement therapy use (for breast cancer controls) [21, 22]. The current study 
only included cancer-free, control participants from the above two nested case-control 
studies. As a higher number of participants were selected from nested case-control study of 
breast cancer, more women than men were part of the current analysis.
Dietary intakes were calculated based on a self-reported food frequency questionnaire (FFQ) 
at cohort entry validated for a multiethnic population [24] and, for a subset of participants, 
also at the time of Qx3. Participants reported their average intake in seven categories and 
serving sizes of specific foods during the last year; dietary intakes were calculated using a 
food composition table that included habitual foods for all race/ethnic groups in the study. 
The mean time interval between cohort entry and the collection of blood samples was 9.1 
years. The mean time between Qx3 and blood draw was 2.1±2.6 years. The final sample size 
for this analysis was 1223 including 312 men and 911 women who had data available for 
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biomarkers examined in the study. Two male participants had missing CRP values and one 
male participant had missing leptin value.
Laboratory assays
All assays were performed by the Analytical Biochemistry Shared Resource at the 
University of Hawaii Cancer Center as reported for the original nested-case control studies 
following the manufacturer’s protocol unless noted otherwise [22, 25]. Briefly, frozen serum 
samples from the MEC biorepository were analyzed in duplicate to quantify leptin and 
adiponectin using a double-antibody enzyme-linked-immunosorbent-assay (R&D Systems, 
Minneapolis, MN, U.S.A.). CRP was assessed using a Cobas MiraPlus clinical chemistry 
analyzer (Roche Diagnostics, Indianapolis, IN) and a latex particle enhanced 
immunoturbidimetry-based kit from Pointe Scientific (Lincoln Park, MI). TNF-α and IL-6 
were included in the Luminex panel and were measured using a slight modification of an 
Invitrogen (Carlsbad, CA) magnetic high sensitivity 10-plex assay (LHC0001) and 
quantified on a Luminex 200 plate reader [22, 25]. As reported previously [22, 25], intra-
batch coefficients of variation based on 96 blinded duplicate and 9 triplet samples for leptin, 
adiponectin, CRP, TNF-α, and IL-6 were 3.4 –6.4%, 2.5–9.4 %, 3.5–5.0%, 10.0%, and 8.9% 
respectively.
Statistical analyses
The SAS software version 9.3 (SAS Institute, Inc., Cary, NC) was used to perform all 
analyses. Multivariable linear models were applied to evaluate the association between red 
and processed meat intake at cohort entry and serum biomarker (leptin, adiponectin, CRP, 
TNF-α, and IL-6) levels measured 9.1±2.5 years later. Dietary intake variables and serum 
biomarkers were log-transformed to satisfy model assumptions. The models were adjusted 
for total energy intake (log-transformed, continuous), laboratory batch (categorical) to 
correct for possible difference across batches, and month of blood draw [binary, winter 
(October–March) or non-winter (April–September) months] to account for seasonal 
variations in biomarker levels based on previous findings showing seasonal variation of 
inflammatory marker levels with the highest levels during the winter months [26, 27]. In 
addition, further adjustment for BMI (log-transformed, continuous) at cohort entry was 
evaluated. The associations between BMI (log-transformed) and serum biomarker levels 
were also assessed using multivariable linear models adjusted for the aforementioned 
covariates, with and without adjustment for red and processed meat intake. All analyses 
were repeated after stratification by race/ethnic group. Interaction terms of red and 
processed meat intake with race/ethnicity were also examined. As age at blood draw, race/
ethnicity, fasting hours prior to blood draw, smoking status, physical activity, and diabetes 
status did not significantly change the results they were not included in the final models. For 
906 (74%) cohort members with Qx3 data (completed within 2 years of blood collection), 
the overall analyses were repeated to examine if diet and BMI (we used both dietary intake 
and BMI values assessed in Qx3) closer to blood draw would result in different findings 
(sensitivity analysis). Spearman’s rank correlation was used to assess the correlation 
between red and processed meat intake at cohort entry and that at Qx3.
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Mediation analysis was performed to determine if BMI mediates the association of red and 
processed meat intake with biomarker levels. Three multivariable linear models were tested: 
the first model (Model 1) examined red and processed meat intake alone (predictor variable) 
as predictor of biomarker levels (outcome variable); the second model (Model 2) tested if 
red and processed meat intake (predictor variable) significantly predicts BMI (mediator); 
and in the third model (Model 3), red and processed meat intake (predictor variable) and 
BMI (mediator) were entered simultaneously to predict biomarker levels (outcome variable). 
Mediation is established if significant associations (P<0.05) are observed in the first and 
second model and two additional criteria are met in the third model: BMI (mediator) must 
significantly predict outcome variable biomarker levels (P<0.05) and the direct relation 
between the predictor and the outcome variables [as indicated by as estimated slope (β) for 
red and processed meat in Model 3] decreases to 0 in case of full mediation or is reduced 
substantially but different from 0 in case of partial mediation [28]. The mediator effect of 
BMI was calculated as the difference in estimated slopes: Mediator effect of BMI=β for red 
and processed meat in Model 1 - β for red and processed meat in Model 3. We also 
estimated percent (%) change in effect for mediator effect of BMI: % change in effect=[Exp 
(β in Model 1) – Exp (β in Model 3)]/ Exp (β in Model 3) x 100%.
RESULTS
The average age at blood draw was 70.2±7.9 years for men and 68.4±7.5 years for women. 
The mean BMI values at cohort entry were 26.5±3.7 kg/m2 and 26.0±5.1 kg/m2 for men and 
women, respectively. Among men, 31.4% were white, 26.0% Japanese American, 18.6% 
Latino, 18.3% African American, and 5.8% Native Hawaiian. The respective race/ethnic 
distributions among women were 22.2%, 33.0%, 20.8%, 15.3%, and 8.8%. At cohort entry, 
9.4% of men and 9.2% women were current smokers, and 4.8% and 7.6% reported diabetes 
(Table 1). Mean estimates of dietary intake of red and processed meat at cohort entry were 
65 g/day in men and 50 g/day in women, both meeting the AICR/WCRF recommendation; 
fruit and vegetable intakes in men (577 g/day) and women (629 g/day) also adhered to the 
AICR and WCRF guidelines [11] (Table 1).
Statistically significant, positive associations between red and processed meat intake and 
serum leptin levels were observed in men (β=0.180, P=0.0004) and women (β=0.167, 
P<0.0001). In women but not men, consumption of red and processed meat was positively 
associated with serum CRP levels (β=0.069, P=0.03) and inversely associated with serum 
adiponectin levels (β= −0.082, P=0.005). The associations between red and processed meat 
consumption and serum levels of TNF-α and IL-6 were not significant for men or women 
(Table 2). Similar results were observed in models restricted to red or processed meat 
although associations between processed meat intake and serum CRP levels were not 
significant (data not shown).
Table 3 shows the association between BMI and serum biomarker levels. Significant, 
positive associations of BMI with serum leptin and CRP levels were observed in men 
(Leptin: β=3.262, P<0.0001; CRP: β=1.173, P=0.0003) and women (Leptin: β=2.923, 
P<0.0001; CRP: β=1.579, P<0.0001). In women, BMI was inversely associated with serum 
adiponectin (β= −1.113, P<0.0001) and positively associated with serum IL-6 levels 
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(β=0.393, P=0.03). These associations between BMI and biomarkers remained significant 
when the model was adjusted for red and processed meat intake (P<0.05).
In mediation analysis, red and processed meat intake was significantly, positively associated 
with BMI in men (β = 0.034, P=0.0004) and women (β = 0.036, P<0.0001). When red and 
processed meat and BMI were simultaneously included as predictors of biomarker levels, the 
significant associations of red and processed meat intake with serum levels of leptin, 
adiponectin and CRP decreased substantially (as indicated by % change in effect: leptin in 
men, 13.4%; Leptin in women, 13.7%; adiponectin in women, −4.7%; CRP in women, 
7.4%) and were no longer significant (P>0.05), suggesting either full or partial mediation by 
BMI (Figure 1). Meanwhile, BMI remained significantly, positively associated with serum 
leptin and CRP in men and women, and inversely associated with serum adiponectin levels 
in women with and without the inclusion of total intake of red and processed meats in the 
model (P<0.05) (Figure 1).
Table 4 shows associations of red and processed meat intake with serum biomarkers by race/
ethnicity. No significant interactions of meat intake with race/ethnicity in relation to 
biomarkers were observed. In women, the associations between red and processed meat 
intake and leptin were significant in African Americans (P=0.03), Latinas (P=0.006), and 
Japanese Americans (P=0.004) but not in whites (P=0.34) and Native Hawaiians (P=0.39). 
Similarly in women, the significantly inverse associations of red and processed meat intake 
with adiponectin levels were observed in African Americans (P=0.03) and Latinas (P=0.03) 
but not in Japanese Americans (P=0.77), Native Hawaiians (P=0.91), and whites (P=0.69). 
Red and processed meat intake was positively associated with serum CRP levels only in 
Latinas (P=0.04) but not in other race/ethnicity groups among women. In men, with the 
exception of an inverse association of red and processed meat intake with serum TNF-α 
levels in whites (P=0.0007), no statistically significant relations were observed across race/
ethnic groups.
The mean intakes of red and processed meat for the 231 men and 675 women with a valid 
diet in Qx3 were 70±58 g and 51±40 g, respectively and the values were highly correlated 
(rs=0.56, p<0.0001) with those at cohort entry. Sensitivity analyses among participants with 
Qx3 data (within two years of blood collection) yielded similar results to those across all 
participants (data not shown). In particular, significant associations in models without BMI 
were no longer significant after including BMI (assessed in Qx3) in the model. For example, 
the respective results before and after BMI adjustment for leptin in women were β=0.109, 
P=0.02 and β= −0.033, P=0.30, respectively. Similarly, the corresponding results for 
adiponectin in women were β= −0.080, P=0.04 and β= −0.052, P=0.16 and for CRP in 
women were β=0.040, P=0.27 and β=0.008, P=0.84.
DISCUSSION
One of the AICR/WCRF cancer prevention recommendations is to limit intake of red meat 
and to avoid eating processed meat [11, 12]. In the present study, red and processed meat 
consumption was positively associated with serum leptin in men and women, and positively 
associated with CRP and inversely associated with serum adiponectin levels in women after 
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nine years of follow-up. However, adjustment for BMI and a mediation analysis indicated 
that these associations were fully or partially mediated by BMI, suggesting that a diet high 
in red and processed meats affects serum obesity-related inflammatory markers through its 
effect on body weight. Using dietary intake and BMI data closer to the time of blood draw 
did not substantially change the results. Recently, a Working Group of the International 
Agency for Research on Cancer (IARC) classified processed meat as carcinogenic based on 
sufficient epidemiologic data for colorectal cancer. The 2016 IARC Working Group further 
concluded that the mechanistic evidence for the carcinogenicity was strong for red meat but 
moderate for processed meat [29]. High iron contents of red meat, particularly heme iron, 
meat processing resulting in formation of carcinogenic chemicals including N-nitroso-
compounds (NOC) and polycyclic aromatic hydrocarbons (PAH), and the production of 
carcinogens such as heterocylic aromatic amines (HAA) and PAH through high-temperature 
cooking may account for the association between red and/or processed meat and cancer [29, 
30]. However, since inflammation is a key risk factor for cancer [1], our results may suggest 
that red and/or processed meat consumption could also affect cancer development through 
the inflammatory pathway.
Our findings are in agreement with previously published literature [14–17]. In a cross-
sectional study, Ley et al. reported that red meat intake was positively associated with serum 
CRP and inversely associated with serum adiponectin levels in 3,690 diabetes-free females. 
However, the associations were attenuated for CRP after adjusting for BMI and for 
adiponectin after adjusting for medical and lifestyle factors [16]. Monton et al. assessed the 
association between the consumption of red meat and circulating high sensitive CRP levels 
with and without the adjustment of BMI in 2,198 men and women and reported similar 
results, but no significant associations between red meat intake and serum adiponectin levels 
were observed even without adjustment of BMI [17]. None of the aforementioned studies 
conducted mediation analysis to evaluate the role of BMI. Furthermore, in an 8-week, 
parallel-designed randomized study, researchers found that partially replacing dietary 
carbohydrate with protein from lean red meat in isoenergetic diets did not increase 
circulating levels of inflammatory markers, such as high sensitive CRP, fibrinogen and 
serum amyloid A protein [31]. The sum of the evidence indicates an indirect association 
between red meat and inflammation through body weight or fat.
As adipose tissue consists of adipocytes, immune cells, and nerve/connective tissue, it is an 
endocrine organ and plays an important role in regulating whole-body metabolism. The pro-
inflammatory phenotype associated with excess fat mass leads to low production of 
adiponectin and high production of leptin, CRP, IL-6, and TNF-α [4]. Our results indicate 
that BMI was significantly, positively associated with serum leptin, CRP, and IL-6 levels and 
inversely associated with serum adiponectin levels, although the associations with IL-6 and 
adiponectin were restricted to women. Additionally, current results also suggest that BMI 
mediated the associations between red and processed meat intake and serum leptin, 
adiponectin and CRP levels, indicating that a diet high in red and processed meat may 
contribute to weight gain and body fat accumulation, which in turn induces the obesity-
related inflammatory process. Therefore, in terms of influencing circulating levels of 
adipokines and inflammatory markers, reducing body fat may be more relevant than 
lowering intake of dietary red and processed meats.
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After stratification by race/ethnic in women, the associations of red and processed meat 
intake with certain biomarkers (e.g., leptin, adiponectin, CRP) were stronger in some race/
ethnicity groups compared to others, although there were no significant interactions with 
race/ethnicity in our study. However, due to the small number of the participants in each 
race/ethnic group, it would not be surprising that some of the associations were not 
statistically significant even when the directions of the associations appeared to be the same. 
The inverse association between red and processed meat intake and TNF-α levels observed 
in white men warrants future investigation with the involvement of more markers in the TNF 
pathway. Previous work reported that processed and unprocessed red meat were inversely 
associated with TNF receptors (sTNF-R1 and sTNF-R2, both considered as pro-
inflammatory cytokines). However, unprocessed red meat consumption was positively 
associated with bioavailable TNF-α, and processed meat intake was inversely associated 
with total TNF-α [18].
To the best of our knowledge, this is the first study to examine the associations of dietary 
intakes of red and processed meat with various circulating inflammatory and adiposity 
biomarkers. The current study is also unique in that we examined a population of five race/
ethnic groups. The multiethnic population and the population-based cohort design strengthen 
the generalizability of the study results. Study limitations include the fact that dietary intake 
was estimated by self-reported FFQs and the long time interval of 9.1 years between cohort 
entry and the collection of blood samples. However, the associations remained similar in a 
subset of participants who provided an updated diet history and BMI within 2 years of the 
blood draw. The fact that the current study population consisted of controls in two nested 
case-control studies of cancer may have introduced selection bias. Another limitation of our 
study was the study design, which prevents the unequivocal determination of temporal 
causal relations between red and processed meat intake, BMI, and serum biomarkers 
associated with obesity and inflammation.
CONCLUSION
Consistent with AICR/WCRF cancer prevention recommendations, the current findings 
suggest that dietary intakes of red and processed meats may be associated with adverse 
health effects such as cancer through an inflammatory pathway in some population groups. 
The current data suggest that the amount of excess body weight or the degree of adiposity 
mediates the association between dietary red and processed meat intake and levels of 
obesity-related serum inflammatory markers.
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Figure 1. 
Figure 1(A, B, C, D) shows the mediator effect of body mass index (BMI) on associations 
between red and processed meat intake (red meat) and serum leptin, adiponectin, and C-
reactive protein (CRP) levels. Three multivariable linear models were applied: 1) In Model 
1, biomarker levels (outcome variable) were regressed on red meat (predictor variable); 2) In 
Model 2, BMI (mediator) was regressed on red meat (predictor variable); 3) In Model 3, 
biomarker levels (outcome variable) were regressed simultaneously on red meat (predictor 
variable) and BMI (mediator). The mediator effect of BMI was estimated as follows: (β for 
red meat in Model 1 [model not including BMI]) - (β for red meat in Model 3 [model 
including BMI]). The percent (%) change in effect for mediator effect of BMI was estimated 
as follows: % change in effect = [Exp (β in Model 1) – Exp (β in Model 3)]/ Exp (β in 
Model 3) x 100%. Variables for red meat, BMI, leptin, adiponectin and CRP were log-
transformed in all analyses.
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Table 1
Characteristics of study participantsa
All Men Women
N 1223 312 911
Age at blood draw (y) 68.9±7.6 70.2±7.9 68.4±7.5
Race/ethnicity, n (%)
 African American 196 (16.0) 57 (18.3) 139 (15.3)
 Latino 247 (20.2) 58 (18.6) 189 (20.8)
 Japanese American 382 (31.2) 81 (26.0) 301 (33.0)
 Native Hawaiian 98 (8.0) 18 (5.8) 80 (8.8)
 White 300 (24.5) 98 (31.4) 202 (22.2)
Time from cohort entry to blood draw 9.1±2.5 8.8±2.5 9.2±2.4
Fasting hours prior to blood drawb 12.6±5.0 11.9±4.2 12.8±5.2
Blood sample collected in winter months (October–March), n (%) 566 (46.3%) 147 (47.1%) 419 (46.0%)
Body mass index at cohort entry (kg/m2) 26.2±4.8 26.5±3.7 26.0±5.1
Current smoking at cohort entry, n (%)b 112 (9.3%) 29 (9.4%) 83 (9.2%)
Diabetes at cohort entry, n (%) 84 (6.9%) 15 (4.8%) 69 (7.6%)
Total energy (kcal/day) 2,017±958 2,279±990 1,927±930
Dietary intake at cohort entry (g/day)
 Unprocessed red meat 37±34 43±33 35±35
 Processed meat (including red and other meats) 17±18 22±22 15±16
 Poultry 46±42 49±43 44±41
 Fish 17±18 19±20 17±18
 Dairy 223±210 219±184 224±218
 Vegetable 339±224 331±217 342±226
 Fruit (not including fruit juice) 277±263 246±234 287±271
 Dietary fiber 25±14 25±14 25±15
Serum biomarker levels
 C-reactive protein (mg/L)b 3.3±4.1 2.9±3.8 3.4±4.1
 Tumor necrosis factor-α (pg/mL) 26.4±157.9 17.3±106.3 29.5±171.9
 Leptin (ng/mL)b 22.3±23.3 9.1±8.4 26.9±25.0
 Adiponectin (μg/mL) 11.4±8.9 8.0±5.6 12.6±9.5
 Interleukin-6 (pg/mL) 11.2±62.4 13.0±78.6 10.6±55.8
a
Data are given as means ± standard deviation unless otherwise specified; percentages may not add to 100 due to rounding.
b
Men had missing data for fasting hours prior to blood draw (N=3), current smoking at cohort entry (N=4), C-reactive protein (N=2), and leptin 
(N=1), and women had missing data for fasting hours prior to blood draw (N=3) and current smoking at cohort entry (N=11).
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